Region: Belgium

Key provisions and IP considerations of the incoming EU CHIPS Act

R&D collaboration entails risk and it is therefore vital for companies to start thinking about the best strategies to adopt

11 January 2023

Extrajudicial admissions: can everything you say be used against you?

In Belgium, no specific provisions exist regarding the admissibility of extrajudicial admissions in court proceedings relating to patents. However, case law shows that the courts will take extrajudicial admissions into account and that it can be difficult for parties to take back such statements.

13 April 2022

How to avoid language barriers when filing patent applications in Belgium

Belgium has a complex institutional system in which the use of official languages is sometimes at the heart of public debate. While the Laws on the Use of Languages in Administrative Matters still play an important role in the lives of Belgians, what are the legal consequences of these laws for Belgian patent applications?

06 April 2022

Measures to enforce Belgian patent rights in court

Civil proceedings can be a formidable option for patent owners to uphold their rights. A range of options, all of which have the goal of matching the damages and the compensation for a rights holder with an infringed patent, means that there is plenty to consider when developing an IP strategy for Belgium.

30 March 2022

Nele D’Halleweyn

Featured in IAM Global Leaders 2022

"The role of patent attorney is a very versatile one. The combination of keeping up with technical innovations together with the legal and commercial implications of inventions ensures that the job remains fascinating and that you have to keep abreast of new technology."

22 November 2021

Belgian materials giant doubles down on IP enforcement in Asia

Umicore has brought a complaint at South Korea’s ITC equivalent and filed a fresh suit in China seeking $39 million from a local competitor

20 September 2021

Benelux Trademark Attorney Firm of the Year: Arnold & Siedsma

Featured in The Global IP Awards: Key Insights from IP Leaders 2020

30 March 2020

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

16 July 2019

AB InBev IP exec explains how he is helping to shift attitudes one six-pack at a time

With the giant brewer facing off against Heineken in court, Michael Swita sets out how innovation and patents are becoming a far bigger consideration in the industry

30 May 2019

Benelux Trademark Attorney Firm of the Year: Chiever

Featured in The Global IP Awards: Key Insights from IP Leaders 2019

23 April 2019

Unlock unlimited access to all IAM content